Third-party tested
Discreet packaging
EU dispatch in 48h

Cabergoline ZPHC — 0.25 mg × 50 tablets

by ZPHC

Caber 0.25mg tablets by ZPHC. Dopamine agonist, prolactin control.

Purity (HPLC): 99%+
Tested by: ZPHC

In stock

Quantity

Pay with Bitcoin or USDT (TRC-20) on this site, or contact a representative for a card or bank payment link. Free EU shipping over €250.

Batch certificate of analysis available on request via Telegram or the contact form.

Research overview

ZPHC Cabergoline 0.25mg is a potent, long-acting dopamine D2 receptor agonist with a 63–69 hour half-life, enabling twice-weekly dosing for sustained prolactin suppression. Originally developed for Parkinson's disease and prolactinoma treatment, cabergoline is studied in androgen research for prolactin regulation arising from 19-nor steroid use, reproductive endocrinology and dopaminergic pathway modulation. Its high D2 selectivity and long half-life distinguish it from shorter-acting dopamine agonists.

50-tablet pack, ZPHC GMP-grade production, Janoshik-verified 99%+ purity. For laboratory research use only.

Specifications

Compound: Cabergoline ZPHC — 0.25 mg × 50 tablets
Purity: 99%+ (HPLC)
Tested by: ZPHC
Brand: ZPHC
Category: PCT & Anti-Estrogen
Storage: Store below 25°C in a cool, dry place, away from light
Intended use: In-vitro and laboratory research only
Shipping: EU, tracked, dispatched within 48 hours of payment

Research use only. All products are sold strictly for in-vitro and laboratory research. Not for human consumption, veterinary use, diagnosis, treatment or prevention of any disease. Must be handled by qualified professionals in a controlled laboratory setting. JuicedPharma makes no therapeutic or medical claims about this compound.